2Gottschalk S,Cristiano RJ,Smith LC,et al,Folate receptor mediated DNA delivery into tumor cells;potosomal disruption results in enhanced gene expression[J].Gene Ther,1994,1(1):185.
3Rojansakuly.Antisense oligonucleotide therapeutics;drug delivery and targeting[J].Adv Drug Delivery Rey,1996,18(2):115.
4Bijsterbosch MK,Berkel TJCV,Native and modified lipoproteins as drug delivery systems[J].Adv Drug Delivery Rev,1990,5(3):231.
5Herrn JN,Gentry CA,Davies SS,et al,Antibodies as targeting moiesties;affinity measurements conjugation chemistry and applistry and applications in immanoliposomes[J].J Controlled Release,1994,28(1-3):155.
6Kuke I,hayashi T,Tabata Y,et al.Synthesis of poly (ethylene glycol)derivatives with different branchings and their use for protein modification[J].J Controlled Release,1994,30(1):27.
2Carhnark A, Hawker C, Hult A, Malkoch M. New methodologies in the construction of dendric materials[J].Chem Soc Rev, 2009,38:352- 362.
3Esfand R,Tomalia D A. Poly(amidoamine) (PAMAM) dendrimers: trom biomimicry to drug delivery and biomedical applications[J]. Drug Discov Today, 2001,6:427- 436.
4Ma M L,Cheng Y Y,Xu Z H,Xu P,Qn H B,Fang Y J. Evaluation of polyamidoamine (PAMAM) dendrimers as drug carriers of anti bacterial drugs using sulfamethoxazole (SMZ) as a model drug[J].Eur J Med Chem,2007,42:93- 98.
5Morgan M T, Nakanislai Y, Kroll D J ,Griset A P,Carnahan M A, Wathier M. Dendrimer encapsulated eamptotheeins:increased solubility, cellular uptake, and cellular retention affords enhanced antieancer activity in vitro[J]. Caiacer Res, 2006,66: 11913- 11921.
6Kolhe P,Khandare J,Pillai O, Kannan S, Lieh Lai M,Kannana R M. Preparation, cellular transport, and activity of poly amidoamine-based dendritic nanodevices with a high drug pay load[J]. Biomaterials, 2006,27 : 660- 669.
7Yang H, Lopina S T. Penicillin V-conjugated PEG PAMAM star polymers[J]. J Biomater Sci Polym Ed, 2003, 14:1043 -1056.
8Patri A K,Kukowska-Latallo J F,Baker J R Jr. Targeted drug delivery with dendrimers: comparison of the release kinetics of covalently conjugated drug and non covalent drug inclusion complex[J]. Adv Drug Delivery Rev, 2005,57 : 2203 -9214.
9Seib F P, Jones A T, Duncan R. Comparison of the endocytic properties of linear and branched PEls, and cationic PAMAM dendrimersin B16f10 melanoma cells[J]. J Contr Rel,2007, 117:291-300.
10PerumaI O P, Inapagolla R, Kannan S, Kannan M R. The effect of surtace functionality on cellular trafficking of dendrimers. Biomaterials,2008,29:3469- 3176.
